Prot #AC-065A308: The efficacy and safety of initial triple versus initial dual oral combination therapy in patients with newly diagnosed pulmonary arterial hypertension: A multi-center, double-blind, placebo-controlled, Phase 3b study

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date6/28/166/28/19

    Funding

    • Chiltern International, Inc. (Prot# AC-065A308)
    • Actelion Pharmaceuticals Ltd. (Prot# AC-065A308)